Aureus Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.75M | Buy |
8,395
+2,253
| +37% | +$1.05M | 0.25% | 51 |
|
|
2025
Q4 | $2.78M | Buy |
6,142
+4,324
| +238% | +$1.86M | 0.18% | 64 |
|
|
2025
Q3 | $712K | Hold |
1,818
| – | – | 0.05% | 107 |
|
|
2025
Q2 | $809K | Sell |
1,818
-335
| -16% | -$154K | 0.05% | 103 |
|
|
2025
Q1 | $1.04M | Sell |
2,153
-33
| -2% | -$15.4K | 0.07% | 95 |
|
|
2024
Q4 | $880K | Hold |
2,186
| – | – | 0.06% | 99 |
|
|
2024
Q3 | $1.02M | Sell |
2,186
-80
| -4% | -$38.4K | 0.07% | 90 |
|
|
2024
Q2 | $1.06M | Hold |
2,266
| – | – | 0.07% | 87 |
|
|
2024
Q1 | $947K | Hold |
2,266
| – | – | 0.06% | 89 |
|
|
2023
Q4 | $922K | Sell |
2,266
-40
| -2% | -$14.8K | 0.07% | 90 |
|
|
2023
Q3 | $802K | Hold |
2,306
| – | – | 0.06% | 97 |
|
|
2023
Q2 | $812K | Sell |
2,306
-77
| -3% | -$25.9K | 0.06% | 96 |
|
|
2023
Q1 | $751K | Hold |
2,383
| – | – | 0.06% | 99 |
|
|
2022
Q4 | $688K | Hold |
2,383
| – | – | 0.06% | 112 |
|
|
2022
Q3 | $690K | Sell |
2,383
-40
| -2% | -$11.5K | 0.06% | 103 |
|
|
2022
Q2 | $683K | Hold |
2,423
| – | – | 0.06% | 107 |
|
|
2022
Q1 | $632K | Hold |
2,423
| – | – | 0.04% | 132 |
|
|
2021
Q4 | $532K | Hold |
2,423
| – | – | 0.03% | 128 |
|
|
2021
Q3 | $440K | Hold |
2,423
| – | – | 0.03% | 139 |
|
|
2021
Q2 | $489K | Hold |
2,423
| – | – | 0.03% | 140 |
|
|
2021
Q1 | $521K | Sell |
2,423
-140
| -5% | -$30.8K | 0.04% | 114 |
|
|
2020
Q4 | $606K | Sell |
2,563
-2,040
| -44% | -$468K | 0.05% | 118 |
|
|
2020
Q3 | $1.25M | Hold |
4,603
| – | – | 0.12% | 72 |
|
|
2020
Q2 | $1.34M | Buy |
4,603
+140
| +3% | +$38K | 0.15% | 65 |
|
|
2020
Q1 | $1.06M | Sell |
4,463
-147
| -3% | -$33.7K | 0.15% | 66 |
|
|
2019
Q4 | $1.01M | Sell |
4,610
-240
| -5% | -$48.6K | 0.11% | 85 |
|
|
2019
Q3 | $822K | Sell |
4,850
-106
| -2% | -$18.8K | 0.1% | 87 |
|
|
2019
Q2 | $909K | Sell |
4,956
-344
| -6% | -$60.1K | 0.11% | 83 |
|
|
2019
Q1 | $975K | Sell |
5,300
-150
| -3% | -$27.7K | 0.13% | 79 |
|
|
2018
Q4 | $903K | Hold |
5,450
| – | – | 0.14% | 75 |
|
|
2018
Q3 | $1.05M | Sell |
5,450
-100
| -2% | -$17.8K | 0.13% | 75 |
|
|
2018
Q2 | $943K | Buy |
5,550
+2,400
| +76% | +$372K | 0.13% | 80 |
|
|
2018
Q1 | $513K | Buy |
3,150
+50
| +2% | +$8.17K | 0.08% | 106 |
|
|
2017
Q4 | $465K | Hold |
3,100
| – | – | 0.07% | 117 |
|
|
2017
Q3 | $471K | Hold |
3,100
| – | – | 0.07% | 111 |
|
|
2017
Q2 | $399K | Buy |
+3,100
| New | +$373K | 0.07% | 111 |
|
Other funds holding VRTX
VCM
VPM
Aureus Asset Management's VRTX Position: Q1 2026 in Review
Aureus Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 37% in Q1 2026, buying an estimated $1.05M and bringing the position to 8,395 shares worth $3.75M. The position accounts for 0.25% of the portfolio, ranked #51.
Aureus Asset Management first reported a position in VRTX in Q2 2017 and has held it in 36 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Aureus Asset Management held 8,395 shares of Vertex Pharmaceuticals worth $3.75M as of Q1 2026.
- Aureus Asset Management bought 2,253 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.05M.
- Vertex Pharmaceuticals made up 0.25% of Aureus Asset Management's portfolio in Q1 2026, its #51 holding.
- Aureus Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 36 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Aureus Asset Management's 13F filing for Q1 2026, filed 13 May 2026.